Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients

(1) Background: Precision oncology is opening new treatment opportunities for patients suffering from solid tumors. In the last two decades, the advent of CDK4/6 inhibitors, immunotherapy, and antibody–drug conjugates (ADC) improved survival outcomes for advanced or metastatic breast cancers (BC). N...

Descripción completa

Detalles Bibliográficos
Autores principales: Falcone, Rosa, Lombardi, Pasquale, Filetti, Marco, Fabi, Alessandra, Altamura, Valeria, Scambia, Giovanni, Daniele, Gennaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954949/
https://www.ncbi.nlm.nih.gov/pubmed/36826152
http://dx.doi.org/10.3390/curroncol30020191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954949/
https://www.ncbi.nlm.nih.gov/pubmed/36826152
http://dx.doi.org/10.3390/curroncol30020191

Ejemplares similares